Benzhydryl Compounds - Research News and Information

Thursday, January 08, 2009

Structural development of benzhydrol-type 1'-acetoxychavicol acetate (ACA) analogs as human leukemia cell-growth inhibitors based on quantitative structure-activity relationship (QSAR) analysis.

29 Sep 2008 Benzhydrol-type analogs of 1'-acetoxychavicol acetate (ACA) were developed as inhibitors of human leukemia HL-60 cell growth based on quantitative structure-activity relationship (QSAR) analysis. An analog containing an anthracenyl moiety (8) was a ... Read more...

Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus.

8 Sep 2008 The lateral hypothalamus (LH) is a central hub that integrates inputs from, and sends outputs to, many other brain areas. Two groups of neurons in the LH, expressing hypocretin/orexin or melanin concentrating hormone (MCH), have been shown to ... Read more...

Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil.

30 Aug 2008 INTRODUCTION: Sleep deprivation alters risk-related judgments, decision-making, and behavioral control. Stimulant medications are used to restore cognitive performance, but their effects on risk-taking and judgment in sleep-deprived subjects have ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Benzhydryl Compounds'

These are the very latest articles for this heading:

• Structural development of benzhydrol-type 1'-acetoxychavicol acetate (ACA) analogs as human leukemia cell-growth inhibitors based on quantitative structure-activity relationship (QSAR) analysis. 29 Sep 2008
• Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. 8 Sep 2008
• Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. 30 Aug 2008
• Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. 18 Aug 2008
• No rest for fatigue researchers. 9 Aug 2008
• Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. 3 Aug 2008
• Use of large-scale chromatography in the preparation of armodafinil. 30 Jul 2008
• Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects. 30 Jul 2008
• Management of patients with obstructive sleep apnea. 30 Jul 2008
• Acceleration tolerance at night with acute fatigue and stimulants. 30 Jul 2008
• Iterative molecular assembly based on the cation-pool method. Convergent synthesis of dendritic molecules. 27 Jul 2008
• Cancer investigators make strides in improving patients' quality of life. 21 Jul 2008
• How many drugs for LUTS due to BPH are too many? 15 Jul 2008
• Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. 15 Jul 2008
• Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. 15 Jul 2008
• Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear. 14 Jul 2008
• Comparison of the effect of heat shock factor inhibitor, KNK437, on heat shock- and chemical stress-induced hsp30 gene expression in Xenopus laevis A6 cells. 8 Jul 2008
• Impact of fesoterodine on quality of life: pooled data from two randomized trials. 29 Jun 2008
• Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome. 29 Jun 2008
• Impact of modafinil on spasticity reduction and quality of life in children with CP. 29 Jun 2008

See a longer list of these articles.

Technical information about 'Benzhydryl Compounds'

Definition: Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.

Registry Number: 0

Descriptor UI: D001559

Alternative terms: Benzhydryl Compounds; Compounds, Benzhydryl; Diphenylmethyl Compounds; Compounds, Diphenylmethyl;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.455.426.559.389.115;

History Note: 75

Technical Notes: DF: BENZHYDRYL CPDS